SLC7A5 and pancreatic neoplasm: Previous studies have examined the association between LAT1 expression and the response to adjuvant chemotherapy in pancreatic cancer [22] and gastric cancer [26], and revealed that patients with high LAT1 expression had shorter survival intervals.